Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TYK Medicines, Inc. Class H ( (HK:2410) ) has issued an update.
TYK Medicines, Inc., a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company’s committees. This announcement provides clarity on the leadership structure of the company, indicating the members and chairpersons of the Audit, Remuneration and Appraisal, Nomination, and Scientific Committees, which could impact the company’s governance and strategic direction.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 2,203,797
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$8.22B
For detailed information about 2410 stock, go to TipRanks’ Stock Analysis page.